CIBMTR data on outcomes and trends are summarized and made available for clinical decision-making, presentations, and research planning.
Using information from our outcomes database, CIBMTR annually prepares and distributes charts summarizing current uses and outcomes of cellular therapies in a set of US Summary Slides.
The US Summary Slides are an annual report on data submitted to CIBMTR by centers in the US and describes information related to practices and general survival outcomes after cellular therapies. The current edition includes procedures performed prior to 2023.
Slides 3 to 49 exhibit data on frequency of transplants according to transplant and CAR–T infusion type, donor, patient age, graft source, graft-versus-host disease (GVHD)prophylaxis, disease, causes of death, conditioning regimen, and race and/or ethnicity. All frequencies represent first autologous and allogeneic transplants and CAR-T infusions registered with the CIBMTR during the period.
Slides 50 to 69 include overall survival outcomes according to age, donor type, disease, disease status, year of infusion, and race and ethnicity. Comparisons across survival curves are univariate and do not adjust for all potentially important factors; consequently, results should be interpreted cautiously.
Summary of the current use, outcomes, trends of adoptive cellular therapies in the United States
In addition to the data and resources available through this website, hematopoietic cell transplantation (HCT) data collected and analyzed by CIBMTR are also available through related websites.
In this section: C.W. Bill Young Cell Transplantation Program website NMDP website
In 2006, CIBMTR was awarded a contract from the Health Resources and Services Administration of the US Department of Health and Human Services to administer the Stem Cell Therapeutic Outcomes Database (SCTOD) of the C.W. Bill Young Cell Transplantation Program.
As a part of this contract, CIBMTR provides statistics about autologous, related, and unrelated allogeneic transplants performed by US transplant centers:
CIBMTR performs a center-specific survival analysis each year as part of the C.W. Bill Young Cell Transplantation Program. The methodology for this analysis (click to view the previous methodology) is reviewed at the Center Outcomes Forum every other year. The results of this analysis are incorporated into a comprehensive guide of all US transplant centers that perform allogeneic transplants (using related or unrelated donors). The listing includes the kinds of transplants performed, transplant outcomes, diseases treated, and general cost information for each center.
Use the form below to request permission to reproduce CIBMTR slides or data. Your request will receive prompt attention.
Publication Permission Request Form
If used publicly, the following statement must be included: “The views expressed in this article are that of the authors and does not reflect the position of the Center for International Blood and Marrow Transplant Research.”
Appropriate credit for CIBMTR data is required.
Except as herein provided, no adaptation of changes shall be made to CIBMTR's materials without prior written consent of CIBMTR.
CIBMTR material shall be used only in the manner as described above. If CIBMTR material is sought for inclusion in a new edition or updated version to a document or publication from which copyright permission is currently being sought, a new CIBMTR Copyright Permission Request Form must be submitted to CIBMTR.